BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11749694)

  • 21. Homozygous deletions of the INK4a/ARF locus in renal cell cancer.
    Kasahara T; Bilim V; Hara N; Takahashi K; Tomita Y
    Anticancer Res; 2006; 26(6B):4299-305. PubMed ID: 17201148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.
    Poi MJ; Yen T; Li J; Song H; Lang JC; Schuller DE; Pearl DK; Casto BC; Tsai MD; Weghorst CM
    Mol Carcinog; 2001 Jan; 30(1):26-36. PubMed ID: 11255261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K
    Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.
    Shintani S; Nakahara Y; Mihara M; Ueyama Y; Matsumura T
    Oral Oncol; 2001 Sep; 37(6):498-504. PubMed ID: 11435176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.
    Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM
    J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The INK4a /ARF locus: role in cell cycle control for renal cell epithelial tumor growth after the Chernobyl accident.
    Romanenko A; Morell-Quadreny L; Lopez-Guerrero JA; Pellin A; Nepomnyaschy V; Vozianov A; Llombart-Bosch A
    Virchows Arch; 2004 Sep; 445(3):298-304. PubMed ID: 15232742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.
    Rizos H; Darmanian AP; Holland EA; Mann GJ; Kefford RF
    J Biol Chem; 2001 Nov; 276(44):41424-34. PubMed ID: 11518711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
    Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
    Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.
    Xiong J; Epstein RJ
    Mol Cancer Ther; 2009 Apr; 8(4):779-85. PubMed ID: 19372550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
    Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.